PACS Group, Inc. (PACS) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $42.88 (+1.97%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | Ben Hendrix | RBC Capital | $52.00 | +21.3% |
| Dec 19, 2025 | Ben Hendrix | RBC Capital | $47.00 | +9.6% |
| Aug 15, 2024 | David MacDonald | Truist Financial | $44.00 | +2.6% |
| Aug 13, 2024 | Michael Wiederhorn | Oppenheimer | $40.00 | -6.7% |
| Jun 28, 2024 | Tao Qiu | Macquarie | $35.00 | -18.4% |
| May 15, 2024 | Michael Wiederhorn | Oppenheimer | $32.00 | -25.4% |
| May 6, 2024 | David MacDonald | Truist Financial | $32.00 | -25.4% |
| May 6, 2024 | Michael Wiederhorn | Oppenheimer | $31.00 | -27.7% |
| May 6, 2024 | Ben Hendrix | RBC Capital | $30.00 | -30.0% |
Top Analysts Covering PACS
PACS vs Sector & Market
| Metric | PACS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +27.0% | +16187.2% | +19.5% |
| P/E Ratio | 27.74 | 3.76 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.71B | $5.72B | $5.73B | 4 |
| 2027-03-31 | $1.49B | $1.51B | $1.52B | 3 |
| 2027-06-30 | $1.53B | $1.54B | $1.56B | 2 |
| 2027-09-30 | $1.56B | $1.58B | $1.60B | 2 |
| 2027-12-31 | $1.60B | $1.62B | $1.64B | 3 |
| 2028-03-31 | $1.62B | $1.63B | $1.65B | 2 |
| 2028-06-30 | $1.65B | $1.67B | $1.69B | 1 |
| 2028-09-30 | $1.70B | $1.71B | $1.74B | 1 |
| 2028-12-31 | $1.75B | $1.76B | $1.79B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.06 | $2.07 | $2.08 | 3 |
| 2027-03-31 | $0.44 | $0.45 | $0.45 | 1 |
| 2027-06-30 | $0.58 | $0.58 | $0.59 | 1 |
| 2027-09-30 | $0.62 | $0.62 | $0.63 | 1 |
| 2027-12-31 | $0.63 | $0.64 | $0.65 | 1 |
| 2028-03-31 | $0.50 | $0.51 | $0.52 | 1 |
| 2028-06-30 | $0.66 | $0.67 | $0.68 | 1 |
| 2028-09-30 | $0.69 | $0.70 | $0.71 | 1 |
| 2028-12-31 | $0.70 | $0.71 | $0.72 | 1 |
Frequently Asked Questions
What is the analyst consensus for PACS?
The consensus among 8 analysts covering PACS Group, Inc. (PACS) is Buy with an average price target of $52.25.
What is the highest price target for PACS?
The highest price target for PACS is $52.00, set by Ben Hendrix at RBC Capital on 2026-03-02.
What is the lowest price target for PACS?
The lowest price target for PACS is $30.00, set by Ben Hendrix at RBC Capital on 2024-05-06.
How many analysts cover PACS?
8 analysts have issued ratings for PACS Group, Inc. in the past 12 months.
Is PACS a buy or sell right now?
Based on 8 analyst ratings, PACS has a consensus rating of Buy (2.00/5) with a +27.0% upside to the consensus target of $52.25.
What are the earnings estimates for PACS?
Analysts estimate PACS will report EPS of $2.07 for the period ending 2026-12-31, with revenue estimated at $5.72B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.